LDB3 p.Ser182Arg
c.544A>C · VCV3614252
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.311 | indeterminate |
|---|---|---|
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · A>G here scores Δ0.85 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 2.1, phastCons 1 |
| Regional constraint | o/e 0.95 | unconstrained · MANE · 64 kb · p 0.14 · regional, not allelic |
| Overall | ||
| CADD | 20.7 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- LDB3
- Protein
- p.Ser182Arg
- Coding
- c.544A>C
- MANE Select
- NM_007078 · reported on NM_001368067
- Type
- single nucleotide variant
- Location
- chr10:86687268 (GRCh38)
- Gene constraint
- LOEUF 0.864 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 61.98 · 2 PDB
- Residue 182
- the 'disordered' region
Disease context
myofibrillar myopathy 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Late-onset distal myopathy, Markesbery-Griggs type (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- LDB3 p.Gly182Asp Uncertain significance ★★ ⚠ same residue
- LDB3 p.Ser182= Benign ★★ same residue
- LDB3 p.Gly182Ser Conflicting classifications of pathogenicity ★ ⚠ same residue
- LDB3 p.Ser182Cys Uncertain significance ★ same residue
- LDB3 p.Gly182= Likely benign ★ same residue
- LDB3 p.Ala147Thr Pathogenic/Likely pathogenic ★★ same condition
- LDB3 p.Ala165Val Pathogenic/Likely pathogenic ★★ same condition
- LDB3 c.1231+4A>C Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ldb3-p-ser182arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown